MJH Logo
  • Access
  • Access
  • Insight
  • Education
  • Access
  • Insight
  • Education
  • Access
  • Insight
  • Education
Products, Services, & Partnerships
Curetoday GBM 1st Annual European Congress on Hematology: Focus on Lymphoid Malignancies 1st Annual European Congress on Immnotherapies in Cancer The future of Lung Cancer The future of Breast Cancer PER Event PER Event PER Event ONCLive SOSS AJMC AMCO SOGO NYGU 34 Chemotherapy Foundation VBOnc SOBO Miami Breast Cancer Giants 2016 MD Mag Pharmacy Times Pharmacy Times OncLive SAP Pharmacy Times
A Full-Service Healthcare Communications Company
 
Michael J. Hennessy Associates, Inc, is dedicated to providing healthcare professionals with the information and resources they need to optimize patient outcomes. As a full-service healthcare communications company, we provide integrated communication products and services, education, and research to the healthcare industry.
 
We have a long-standing reputation for offering timely, relevant, and practical information that meets the needs of our diverse audience. Our Integrated Communications Division features an established, comprehensive network of media products that reaches an impressive array of healthcare decision makers, including physicians, pharmacists, managed care professionals, physician assistants, nurse practitioners, nurses, and patients.
 
We also combine the reach and influence of our powerful portfolio of print and digital product lines, live events and conferences, educational programs, and custom market research with the customer-service focus and customization capabilities of a boutique firm. Our clients include world-leading pharmaceutical, medical device, diagnostic, and biotech companies within the industry.

Leading Brands, Broadest Reach
The American Journal of Accountable CareFamily Practice RecertificationThe American Journal of Managed CareThe American Journal of Pharmacy BenefitsArcmesaCardiology Review OnlineContemporary OncologyCure TodayDentists' Money DigestOncology Business ManagementPharmacy TimesGiants of Cancer CareOncology FellowsAmerican Journal of Hematology / OncologyInternal Medicine World ReporCure ConnectionsIntellisphereMD MagazineContemporary ClinicResident and Staff PhyisicianPhysician's Money DigestOncologueMedical CrossfireInteractive PublicationsSurgical RoundsPhysicians Financial newsMedical World NewsOncLiveEvidence-Based OncologyRare Disease CommunicationsPain ManagementPharmacy Times Continuing EducationOncLive InsightsRare Disease ReportThe Educated PatientOncology and Biotech NewsHRA ResearchOncLive News NetworkSpecialty Pharmacy TimesPhysicians Education ResourceOncLive Peer ExchangeUrologists in Cancer CareOncology Nursing NewsMD MagazineTargeted Oncology
The Latest
from MJH Associates

OncLive Seeks Nominations for 5th Annual Giants of Cancer Care Awards
OncLive is seeking nominations for its 2017 Giants of Cancer Care Awards, which recognizes the top oncologists and researchers who have made remarkable achievements in oncology research and clinical practice, announced OncLive President Michael J. Hennessy, Jr.

Specialty Pharmacy Times Partners with Ochsner Health System and Vanderbilt University Medical Center
Specialty Pharmacy Times, the specialty pharmacy industrys leading journal and most-read publication among specialty pharmacists and pharmacy professionals, has teamed up with Ochsner Health System and Vanderbilt University Medical Center through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of Pharmacy Healthcare Communications, LLC, publishers of Specialty Pharmacy Times. The partnership provides Ochsner and Vanderbilt pharmacy professionals with unlimited access to Specialty Pharmacy Times print and digital content as well as their library of continuing education.

Michael J. Hennessy Associates, Inc. Launches New Center for Biosimilars Website
Michael J. Hennessy Associates, Inc., launched a new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael J. Hennessy, Jr. The redesigned website will include the latest developments in the field of biosimilars through thought leader interaction in, live video and interactive digital platforms.


Our Audience